Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Equity Incentive Plan	Private Placement	At-the-market Offering	Employee stock purchase plan contingently issuable	Common Stock	Common Stock Equity Incentive Plan	Common Stock Private Placement	Common Stock At-the-market Offering	Common Stock Employee stock purchase plan contingently issuable	Additional Paid-In Capital	Additional Paid-In Capital Equity Incentive Plan	Additional Paid-In Capital Private Placement	Additional Paid-In Capital At-the-market Offering	Additional Paid-In Capital Employee stock purchase plan contingently issuable	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022						36,956,345
Beginning balance at Dec. 31, 2022	$ 142,037					$ 4					$ 535,074					$ (392,824)	$ (217)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock in private placement, net of issuance costs / issuance of common stock in at-the-market offerings, net of issuance costs (in shares)								8,000,000	658,206
Common stock (in shares)			$ 202,204	$ 14,480				$ 1					$ 202,203	$ 14,480
Issuance of common stock in connection with asset acquisition (in shares)						231,624
Issuance of common stock in connection with asset acquisition	5,188										5,188
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)							760,226			116,742
Issuance of common stock in connection with equity award plans / employee stock purchase plan		$ 8,279			$ 2,191							$ 8,279			$ 2,191
Stock-based compensation	35,845										35,845
Net loss	(163,415)															(163,415)
Other comprehensive (loss) income	1,861																1,861
Ending balance (in shares) at Dec. 31, 2023						46,723,143
Ending balance at Dec. 31, 2023	248,670					$ 5					803,260					(556,239)	1,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)							1,489,510			125,443
Issuance of common stock in connection with equity award plans / employee stock purchase plan		15,059			2,640							15,059			2,640
Stock-based compensation	49,230										49,230
Net loss	(87,942)															(87,942)
Other comprehensive (loss) income	(2,017)																(2,017)
Ending balance (in shares) at Dec. 31, 2024						48,338,096
Ending balance at Dec. 31, 2024	225,640					$ 5					870,189					(644,181)	(373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with equity award plans / employee stock purchase plan (in shares)							3,450,566			106,977
Issuance of common stock in connection with equity award plans / employee stock purchase plan		$ 36,200			$ 3,942							$ 36,200			$ 3,942
Conversion of convertible notes, net (in shares)						752
Conversion of convertible notes, net	24										24
Stock-based compensation	71,523										71,523
Net loss	(23,363)															(23,363)
Other comprehensive (loss) income	724																724
Ending balance (in shares) at Dec. 31, 2025						51,896,391
Ending balance at Dec. 31, 2025	$ 314,690					$ 5					$ 981,878					$ (667,544)	$ 351